Calton & Associates’s Seagen Inc. Common Stock SGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding SGEN
BBA
MCMC
Calton & Associates's SGEN Position: Q1 2018 in Review
Calton & Associates sold out of Seagen Inc. Common Stock (SGEN) in Q1 2018, closing a stake of 500 shares — an estimated $28K sold.
Calton & Associates first reported a position in SGEN in Q4 2017 and held it in 1 quarter. The position peaked at $28K in Q4 2017. 287 funds tracked by Wall St. Rank hold SGEN as of Q1 2018.
- Calton & Associates reported no remaining Seagen Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
- Calton & Associates sold 500 Seagen Inc. Common Stock shares in Q1 2018, an estimated $28K.
- Calton & Associates first reported a position in Seagen Inc. Common Stock in Q4 2017 and held it in 1 quarter.
- Calton & Associates's Seagen Inc. Common Stock position peaked at $28K in Q4 2017.
- 287 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2018.
Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.